It is rare for companies to last more than five years, with many struggling to reach the age of 10. However, Intuitive Surgical (NASDAQ: ISRG) has been thriving since its creation in 1995. The medical device specialist is a leader in robotic surgery, with its da Vinci system allowing for minimally invasive procedures. This has led to increased revenue and earnings for the company.
The adoption of robotic-assisted surgery is still in its early stages, with significant growth potential. Intuitive Surgical has a wide competitive advantage with its installed base of 8,887 robots, attracting new healthcare facilities looking for robotic devices.
Despite facing headwinds such as the impact of the COVID-19 pandemic on procedure volume and competition in the market, Intuitive Surgical remains well-positioned for long-term success. The company’s strong track record, consistent revenue and earnings, and industry leadership make it a stock worth holding for the next decade.
Investors should consider the potential for significant returns in the coming years. While Intuitive Surgical may not be among the top 10 stocks recommended by the Motley Fool Stock Advisor analyst team, it remains a solid investment choice. With its strong position in a growing industry, the company is a no-brainer growth stock to buy and hold for the long term.